CompletedPhase 2NCT01548690
Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
Studying Acute liver failure
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- William Lee
- Principal Investigator
- William M Lee, MDUniversity of Texas Southwestern Medical Center
- Intervention
- Ornithine Phenylacetate(drug)
- Enrollment
- 47 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2012 – 2017
Study locations (11)
- University of California, San Francisco, San Francisco, California, United States
- Yale University School of Medicine, New Haven, Connecticut, United States
- Emory University, Atlanta, Georgia, United States
- Northwestern University, Chicago, Illinois, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- University of Michigan Medical Center, Ann Arbor, Michigan, United States
- The Ohio State University, Columbus, Ohio, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- University of Texas Southwestern Medical Center, Dallas, Texas, United States
- Virginia Commonwealth University, Richmond, Virginia, United States
- University of Washington, Seattle, Washington, United States
Collaborators
Medical University of South Carolina · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Ocera Therapeutics
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01548690 on ClinicalTrials.govOther trials for Acute liver failure
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07409259PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver FailureThird Affiliated Hospital, Sun Yat-Sen University
- ENROLLING BY INVITATIONNANCT06987604Continuous Renal Replacement Therapy Intensity in HyperammonemiaHospital de Clinicas de Porto Alegre
- RECRUITINGNANCT06831643Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver FailureInstitute of Liver and Biliary Sciences, India
- ACTIVE NOT RECRUITINGNANCT06872372Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver FailureLahore General Hospital
- RECRUITINGNCT06908746Efficacy and Safety of Citrate Anticoagulation in CRRT for Patients With Liver Failure/DysfuncTION, the CAUTION Trial! A Retrospective Study on Etiology of Liver Failure and Their ComplicationsUniversity Hospital, Antwerp
- ENROLLING BY INVITATIONNCT06893042Clinical Study of Pediatric Acute Liver FailureFansen Zeng
- RECRUITINGNANCT07329036ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLFInstitute for Clinical and Experimental Medicine
- RECRUITINGPHASE1, PHASE2NCT05989958The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver FailureHexaell Biotech Co., Ltd.